2itx: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:2itx.jpg|left|200px]]
[[Image:2itx.jpg|left|200px]]


{{Structure
<!--
|PDB= 2itx |SIZE=350|CAPTION= <scene name='initialview01'>2itx</scene>, resolution 2.98&Aring;
The line below this paragraph, containing "STRUCTURE_2itx", creates the "Structure Box" on the page.
|SITE= <scene name='pdbsite=AC1:Anp+Binding+Site+For+Residue+A+2020'>AC1</scene>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
|LIGAND= <scene name='pdbligand=ANP:PHOSPHOAMINOPHOSPHONIC+ACID-ADENYLATE+ESTER'>ANP</scene>
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span>
or leave the SCENE parameter empty for the default display.
|GENE=  
-->
|DOMAIN=
{{STRUCTURE_2itx| PDB=2itx  | SCENE= }}  
|RELATEDENTRY=[[1xkk|1XKK]], [[2itn|2ITN]], [[2ito|2ITO]], [[2itp|2ITP]], [[2itq|2ITQ]], [[2itt|2ITT]], [[2itu|2ITU]], [[2itv|2ITV]], [[2itw|2ITW]], [[2ity|2ITY]], [[2itz|2ITZ]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2itx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2itx OCA], [http://www.ebi.ac.uk/pdbsum/2itx PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2itx RCSB]</span>
}}


'''CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP'''
'''CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP'''
Line 33: Line 30:
[[Category: Woo, S.]]
[[Category: Woo, S.]]
[[Category: Yun, C H.]]
[[Category: Yun, C H.]]
[[Category: alternative splicing]]
[[Category: Alternative splicing]]
[[Category: amp-pnp]]
[[Category: Amp-pnp]]
[[Category: anp]]
[[Category: Anp]]
[[Category: anti-oncogene]]
[[Category: Anti-oncogene]]
[[Category: atp-binding]]
[[Category: Atp-binding]]
[[Category: cell cycle]]
[[Category: Cell cycle]]
[[Category: disease mutation]]
[[Category: Disease mutation]]
[[Category: egfr]]
[[Category: Egfr]]
[[Category: epidermal growth factor]]
[[Category: Epidermal growth factor]]
[[Category: glycoprotein]]
[[Category: Glycoprotein]]
[[Category: kinase]]
[[Category: Kinase]]
[[Category: membrane]]
[[Category: Membrane]]
[[Category: nucleotide-binding]]
[[Category: Nucleotide-binding]]
[[Category: phosphorylation]]
[[Category: Phosphorylation]]
[[Category: polymorphism]]
[[Category: Polymorphism]]
[[Category: receptor]]
[[Category: Receptor]]
[[Category: transferase]]
[[Category: Transferase]]
[[Category: transmembrane]]
[[Category: Transmembrane]]
[[Category: tyrosine-protein kinase]]
[[Category: Tyrosine-protein kinase]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 07:52:05 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 03:48:36 2008''

Revision as of 07:52, 4 May 2008

File:2itx.jpg

Template:STRUCTURE 2itx

CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP


OverviewOverview

Mutations in the EGFR kinase are a cause of non-small-cell lung cancer. To understand their mechanism of activation and effects on drug binding, we studied the kinetics of the L858R and G719S mutants and determined their crystal structures with inhibitors including gefitinib, AEE788, and a staurosporine. We find that the mutations activate the kinase by disrupting autoinhibitory interactions, and that they accelerate catalysis as much as 50-fold in vitro. Structures of inhibitors in complex with both wild-type and mutant kinases reveal similar binding modes for gefitinib and AEE788, but a marked rotation of the staurosporine in the G719S mutant. Strikingly, direct binding measurements show that gefitinib binds 20-fold more tightly to the L858R mutant than to the wild-type enzyme.

About this StructureAbout this Structure

2ITX is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity., Yun CH, Boggon TJ, Li Y, Woo MS, Greulich H, Meyerson M, Eck MJ, Cancer Cell. 2007 Mar;11(3):217-27. PMID:17349580 Page seeded by OCA on Sun May 4 07:52:05 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA